M.‐C. Poon

Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study

Brian M. Feldman, Menaka Pai, Georges‐Étienne Rivard et al. · Journal of Thrombosis and Haemostasis · 2006 · 237 citations · Full text

Hematology, Interim Results, Bleeding Disorder +4

Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China

Runhui Wu, K. H. Luke, M.‐C. Poon et al. · Haemophilia · 2010 · 106 citations

Antibodies to Human T-Cell Leukemia Virus Membrane Antigens (HTLV-MA) in Hemophiliacs

Max Essex, M. F. McLane, Tae Hoon Lee et al. · Science · 1983 · 102 citations

Histocompatibility, Immunology, Pathology +17

The international prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention

M.‐C. Poon, R. d' Oiron, R. B. Zotz et al. · Haematologica · 2015 · 86 citations · Full text

Thrombosis, Adult Cardiac Surgery, Blood Platelet +15

Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.

M.‐C. Poon, Roseline d’Oiron · PubMed · 2000 · 61 citations

Factor Vii, Platelet Pathobiology, Thrombosis +21